Blood clotting problems in sepsis patients in the ICU
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how often sepsis leads to blood clotting issues in critically ill patients, and what happens to those patients. It aims to help doctors better understand and treat this complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are admitted to the intensive care unit (ICU) with sepsis
- You are not pregnant
- You do not have a pre-existing bleeding or clotting disorder
- You are not taking blood-thinning medications (anticoagulants)
- You do not have end-stage organ disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.
This trial tests if the drug Sivelestat can help people in the intensive care unit who have septic shock and a specific type of blood clotting problem. It aims to improve survival and recovery.
This study looks for early signs of dangerous blood clotting complications (called DIC) in patients admitted to intensive care with severe infection. Finding these signs early may help doctors treat the problem faster and improve outcomes.
This study is testing a new blood test that looks at how well your blood clots to see if it can help find sepsis (a severe response to infection) earlier. It is for adults who might have an infection, but you cannot be taking certain medications or have certain health conditions.
This trial studies how well the body's natural clot-busting system works in people with serious infections or major injuries. It may help doctors find better ways to treat these conditions.
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
Hear when a new Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.